Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Buprenorphine
Butec
Not routinely available
SMC (1213/17)
29/03/2023
Indication
In adults, for the treatment of chronic non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. SMC restriction: for use in elderly patients (over 65 years).
Therapeutic Area
Central nervous system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
5, 10, 15 and 20 microgram/hour transdermal patch
Comments
-